Yale University School of Medicine, New Haven, CT 06510, USA.
Department of Radiology & Biomedical Imaging, Section of Vascular & Interventional Radiology, Yale University School of Medicine, New Haven, CT 06510, USA.
Future Cardiol. 2023 Jan;19(1):29-38. doi: 10.2217/fca-2022-0100. Epub 2023 Jan 13.
There is increasing evidence that early and comprehensive removal of thrombus in deep vein thrombosis is associated with improved outcomes, including decreased incidence of post-thrombotic syndrome and debilitating long-term symptoms. Catheter-directed thrombolysis is effective for the rapid removal of clot, but it is associated with high bleeding risk. Percutaneous mechanical thrombectomy is a highly effective method for the removal of clot without the use of systemic or catheter-directed thrombolytic therapy. The Inari ClotTriever system (Inari Medical Inc., CA, USA) is a thrombectomy device, which is approved for deep vein thrombosis by the US FDA in 2017. Herein we review the current treatment strategies using the ClotTriever system, its specifications, indications and current state of literature.
越来越多的证据表明,深静脉血栓形成中早期和全面的血栓清除与改善结果相关,包括降低血栓后综合征和致残性长期症状的发生率。导管定向溶栓治疗可有效快速清除血栓,但出血风险高。经皮机械血栓切除术是一种无需全身或导管定向溶栓治疗即可有效清除血栓的方法。Inari 血栓切除术系统(Inari Medical Inc.,CA,美国)是一种血栓切除术装置,于 2017 年获得美国食品药品监督管理局批准用于深静脉血栓形成。本文综述了目前使用血栓切除术系统的治疗策略,包括其规格、适应证和现有文献状态。